An in-depth analysis of 50+ companies and 65+ pipeline drugs shaping the Molecular Glue market. The report covers therapeutics assessment by product type, development stage, route of administration, ...

Obesity is a raging conversation globally now, and manufacturing of generics will pick up after the patent expires.' ...

Japan's UA Zensen, a labour union group representing retail, restaurant and other industry unions, says that its member ...

Meanwhile, a New Drug Application (NDA) for another one of Ascentage Pharma’s key drug candidates, the novel Bcl-2 selective inhibitor lisaftoclax (APG-2575), has already been accepted and granted the ...

Jazz Pharmaceuticals plc is buying Chimerix Inc. for $8.55 a share, bringing the deal in at about $935 million. Jazz expands its cancer pipeline with the new acquisition’s lead candidate, dordaviprone ...

As multinational companies expand their footprint in India, leveraging the country’s technological prowess and digital ...

The global orphan drug market size was USD 154.20 Billion in 2022 and is expected to register a rapid revenue CAGR of 12.3 % ...

Welcome to the first edition of Changing Faces for 2025. January kicked off the year with a flurry of notable leadership ...

The latest data identifies biohealth as a bright spot in VC funding for female founders, most significantly in the Northeast.

The global varicella vaccines market is set for consistent growth, with revenue expected to reach USD 3,258.6 million in 2024 and expand at a CAGR of 2.4% through 2034, ultimately reaching USD 4,115.4 ...

DelveInsight's "XPOVIO Market Size, Forecast, and Market Insight Report" highlights the details around XPOVIO, a ...

Martin Makary, President Donald Trump's nominee to run the U.S. FDA, will be tasked with maintaining the agency's gold ...